Key Clinical Message
The authors urge clinicians to observe the early signs of lower gastrointestinal bleeding and perforation associated with tocilizumab treatment in patients with COVID-19. On-time recognition and performance of exploratory laparotomy with double-barrel colostomy are effective life-saving measures.